Interaction between specific dietary factors and experimental chemotherapy of metastatic melanoma.
The single and combined effects of (a) dietary restriction of phenylalanine and tyrosine, (b) levodopa methylester chemotherapy, and (c) megadose sodium ascorbate supplementation on experimental metastasis was determined in B16-BL6 melanoma. Dietary restriction and levodopa methylester therapy inhibited tumor outgrowth, whereas ascorbate alone was inactive. In combination, however, the effect of dietary restriction and levodopa methylester chemotherapy was augmented by sodium ascorbate. Tumor cells surviving this combination therapy (treated population) were isolated from the lungs of treated mice, and proved to be tumorigenic when inoculated SC into the back of naive mice. The resulting tumors grew more slowly than those produced by inoculation of similarly isolated control cells (control population), irrespective of whether the diet was adequate or deficient in phenylalanine and tyrosine. Failure of the treated tumor cell population to exhibit reduced sensitivity to the combination chemotherapy or, unlike the control population, to exhibit variation in pigmentation levels, suggests that the restriction of phenylalanine and tyrosine during drug therapy alters the tumor response to reduce heterogeneity and perhaps interferes with the emergence of drug resistance.
G G
GG
Meadows
R M
RM
Abdallah
J R
JR
Starkey
D000818:Animals; D001205:Ascorbic Acid / Q000008:administration & dosage*; D004032:Diet; D005260:Female; D007980:Levodopa / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008175:Lung Neoplasms / Q000556:secondary; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D051379:Mice; D008815:Mice, Inbred Strains; D010649:Phenylalanine / Q000008:administration & dosage*; D014443:Tyrosine / Q000008:administration & dosage*
D014443:Tyrosine; D007980:Levodopa; D010649:Phenylalanine; C035420:levodopa methyl ester; D001205:Ascorbic Acid